Pathogen Reduction Technology Treatment of Platelets, Plasma and Whole Blood Using Riboflavin and UV Light
- 1 January 2011
- journal article
- Published by S. Karger AG in Transfusion Medicine and Hemotherapy
- Vol. 38 (1) , 8-18
Abstract
Bacterial contamination and emerging infections combined with increased international travel pose a great risk to the safety of the blood supply. Tests to detect the presence of infection in a donor have a ‘window period’ during which infections cannot be detected but the donor may be infectious. Agents and their transmission routes need to be recognized before specific tests can be developed. Pathogen reduction of blood components represents a means to address these concerns and is a proactive approach for the prevention of transfusion-transmitted diseases. The expectation of a pathogen reduction system is that it achieves high enough levels of pathogen reduction to reduce or prevent the likelihood of disease transmission while preserving adequate cell and protein quality. In addition the system needs to be nontoxic, non-mutagenic and should be simple to use. The Mirasol® Pathogen Reduction Technology (PRT) System for Platelets and Plasma uses riboflavin (vitamin B2) plus UV light to induce damage in nucleic acid-containing agents. The system has been shown to be effective against clinically relevant pathogens and inactivates leukocytes without significantly compromising the efficacy of the product or resulting in product loss. Riboflavin is a naturally occurring vitamin with a well-known and well-characterized safety profile. The same methodology is currently under development for the treatment of whole blood, making pathogen reduction of all blood products using one system achievable. This review gives an overview of the Mirasol PRT System, summarizing the mechanism of action, toxicology profile, pathogen reduction performance and clinical efficacy of the process.Keywords
This publication has 65 references indexed in Scilit:
- Transfusion-transmitted diseases: risks, prevention and perspectivesEuropean Journal of Haematology, 2009
- An Action Spectrum of the Riboflavin-photosensitized Inactivation of Lambda Phage¶Photochemistry and Photobiology, 2005
- Riboflavin and UV-Light Based Pathogen Reduction: Extent and Consequence of DNA Damage at the Molecular LevelPhotochemistry and Photobiology, 2004
- Will Blood Transfusion Ever Be Safe Enough?JAMA, 2000
- Micronucleus tests in mice on 39 food additives and eight miscellaneous chemicalsFood and Chemical Toxicology, 1988
- Human requirements for riboflavinThe American Journal of Clinical Nutrition, 1987
- DNA BREAKAGE CAUSED BY 334‐nm ULTRAVIOLET LIGHT IS ENHANCED BY NATURALLY OCCURRING NUCLEIC ACID COMPONENTS AND NUCLEOTIDE COENZYMESPhotochemistry and Photobiology, 1984
- Photodegradation of DNA with fluorescent light in the presence of riboflavin, and photoprotection by flavin triplet-state quenchersBiochimica et Biophysica Acta (BBA) - Nucleic Acids and Protein Synthesis, 1980
- Phototherapy for neonatal hyperbilirubinemia—a potential environmental health hazard to newborn infants: A reviewEnvironmental Mutagenesis, 1979
- Studies on the interactions between DNA and flavinsBiochimica et Biophysica Acta (BBA) - Nucleic Acids and Protein Synthesis, 1977